378 related articles for article (PubMed ID: 26409265)
1. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
2. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome.
Fukushima H; Inoue T; Takama Y; Ishii N; Okuno T; Kobayashi Y; Yoneda A; Nakamura T; Kuki I; Hara J
Pathol Int; 2017 Oct; 67(10):503-509. PubMed ID: 28971571
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
Storz C; Bares R; Ebinger M; Handgretinger R; Tsiflikas I; Schäfer JF
BMC Med Imaging; 2019 Aug; 19(1):70. PubMed ID: 31429709
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Burke MJ; Cohn SL
Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
[TBL] [Abstract][Full Text] [Related]
6. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
[TBL] [Abstract][Full Text] [Related]
7. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
Pranzatelli MR; Tate ED; McGee NR
Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
[TBL] [Abstract][Full Text] [Related]
8. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
[TBL] [Abstract][Full Text] [Related]
10. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
[TBL] [Abstract][Full Text] [Related]
11. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
[TBL] [Abstract][Full Text] [Related]
12. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
[TBL] [Abstract][Full Text] [Related]
13. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
[TBL] [Abstract][Full Text] [Related]
14. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.
Mizia-Malarz A; Stolpa W; Sobol-Milejska G
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823831
[No Abstract] [Full Text] [Related]
15. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic neurological syndrome in 12 children].
Xiao J; Liu LY; Wu Y; Han TL; Wang X
Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):598-600. PubMed ID: 23158737
[TBL] [Abstract][Full Text] [Related]
17. Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature.
Urtiaga Valle S; Souvannanorath S; Leboucq N; Haouy S; Rivier F; Roubertie A; Meyer P
Eur J Paediatr Neurol; 2022 Sep; 40():18-27. PubMed ID: 35926472
[TBL] [Abstract][Full Text] [Related]
18. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome.
Brunklaus A; Pohl K; Zuberi SM; de Sousa C
Arch Dis Child; 2012 May; 97(5):461-3. PubMed ID: 21460401
[TBL] [Abstract][Full Text] [Related]
19. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
Gupta A; Kundal R; Pandey M
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
Chang BH; Koch T; Hopkins K; Malempati S
Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
